Immunologically ‘hot’ tumors are characterized by the presence of a large number of infiltrating CD8+ cytotoxic T cells (CTLs) and antigen-presenting cells (such as dendritic cells (DCs)), and rapid and sustained tumor clearance can often be achieved when tumors with this type of profile are treated with ICBs. Here, CD8A is linked to neoplasm.